- Home
- SSP vs MYO Comparison
SSP vs MYO Comparison
Compare SSP & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSP
- MYO
- Stock Information
- Founded
- SSP 1878
- MYO 2004
- Country
- SSP United States
- MYO United States
- Employees
- SSP N/A
- MYO N/A
- Industry
- SSP Broadcasting
- MYO Industrial Specialties
- Sector
- SSP Industrials
- MYO Health Care
- Exchange
- SSP Nasdaq
- MYO Nasdaq
- Market Cap
- SSP 177.0M
- MYO 157.9M
- IPO Year
- SSP 1988
- MYO 2017
- Fundamental
- Price
- SSP $2.02
- MYO $6.23
- Analyst Decision
- SSP Buy
- MYO Strong Buy
- Analyst Count
- SSP 2
- MYO 4
- Target Price
- SSP $5.75
- MYO $8.25
- AVG Volume (30 Days)
- SSP 540.3K
- MYO 368.8K
- Earning Date
- SSP 11-04-2024
- MYO 11-06-2024
- Dividend Yield
- SSP N/A
- MYO N/A
- EPS Growth
- SSP N/A
- MYO N/A
- EPS
- SSP N/A
- MYO N/A
- Revenue
- SSP $2,397,162,000.00
- MYO $25,239,125.00
- Revenue This Year
- SSP $10.34
- MYO $53.19
- Revenue Next Year
- SSP N/A
- MYO $39.01
- P/E Ratio
- SSP N/A
- MYO N/A
- Revenue Growth
- SSP 1.66
- MYO 36.23
- 52 Week Low
- SSP $1.68
- MYO $2.51
- 52 Week High
- SSP $9.35
- MYO $6.75
- Technical
- Relative Strength Index (RSI)
- SSP 45.29
- MYO 61.36
- Support Level
- SSP $1.90
- MYO $5.80
- Resistance Level
- SSP $2.24
- MYO $6.14
- Average True Range (ATR)
- SSP 0.17
- MYO 0.47
- MACD
- SSP -0.01
- MYO -0.05
- Stochastic Oscillator
- SSP 20.63
- MYO 57.33
About SSP E.W. Scripps Company (The)
The E W Scripps Co is a media enterprise with interests in local and national media brands. It owns and operates a collection of daily and community newspapers in medium-sized cities in the southern and western portions of the United States. The company's operating segment includes Local Media, Scripps Networks, and Other. It generates maximum revenue from the Local Media segment. The Local Media segment includes local broadcast stations and their related digital operations.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).